共 76 条
[1]
Alavinia SM(2009)Some epidemiological aspects of cutaneous leishmaniasis in Northern Khorasan Province, Iran J Arthropod-Borne Dis 3 50-54
[2]
Arzamani K(2007)The berberis story: Pak J Pharm Sci 20 83-92
[3]
Reihani MH(2007) L. in therapeutics J Infect Dis 196 591-598
[4]
Jafari J(2008)Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis Acta Med Iran 46 191-196
[5]
Arayne MS(2006)Evaluation of miltefosine against Iran J Parasitol 1 39-42
[6]
Sultana N(2007) (MRHO/IR/75/ER): in vitro and in vivo studies Parasitol Res 101 1319-1322
[7]
Bahadur SS(2007)Treatment of cutaneous leishmaniasis in murine model by alcoholic extract of J Sch Publ Health Inst Publ Health Res 5 35-42
[8]
Bhattacharya SK(2012)Glucantime-resistant Parasitol Res 111 2115-2121
[9]
Sinha PK(2007) isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs Med J Aust 186 315-317
[10]
Sundar S(2008)The effect of an alcoholic extract of Parasitol Res 103 1273-1278